US Patent No: 7,514,100

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

ALSO PUBLISHED AS: 20040047907
3 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT283

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, NJ 51 1020
Masselink, John K Old Tappan, NJ 22 195
Oshlack, Benjamin New York, NY 207 5837
Tonelli, Alfred P Congers, NY 23 260

Cited Art Landscape

Patent Info (Count) # Cites Year
 
PHARMACIA & UPJOHN (1)
5,614,218 Controlled release preparation 38 1994
 
Duphar International Research B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 25 1990
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 61 1986
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 58 1988
 
Richardson-Vicks Inc. (1)
4,996,047 Sustained release drug-resin complexes 80 1988
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 178 1992
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 77 1988
5,024,842 Annealed coats 75 1990
5,460,826 Morphine therapy 95 1994
6,491,945 Hydrocodone therapy 25 1994
5,593,695 Morphine therapy 38 1995
5,866,161 Hydrocodone therapy 29 1996
5,667,805 Morphine therapy 30 1996
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 36 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 46 1994
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 63 1982
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 67 1990
 
EURO-CELTIQUE S.A. (12)
4,443,428 Extended action controlled release compositions 89 1982
* 4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 124 1986
5,071,646 Pharmaceutical ion exchange resin composition 111 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 140 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 137 1993
5,670,172 Pharmaceutical spheroid formulation 70 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 106 1996
5,891,471 Pharmaceutical multiparticulates 94 1996
5,843,480 Controlled release diamorphine formulation 74 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 103 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 103 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 42 2001
 
PURDUE PHARMA L.P. (25)
4,828,836 Controlled release pharmaceutical composition 178 1987
4,834,985 Controlled release pharmaceutical composition 195 1987
4,990,341 Controlled release hydromorphone composition 122 1989
5,266,331 Controlled release oxycodone compositions 148 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 184 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 179 1992
5,549,912 Controlled release oxycodone compositions 141 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 163 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 146 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 158 1993
5,411,745 Powder-layered morphine sulfate formulations 96 1994
5,965,161 Extruded multi-particulates 113 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 367 1995
5,508,042 Controlled release oxycodone compositions 148 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 157 1995
5,958,459 Opioid formulations having extended controlled released 94 1995
5,656,295 Controlled release oxycodone compositions 127 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 91 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 156 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 108 1997
5,958,452 Extruded orally administrable opioid formulations 142 1997
6,103,261 Opioid formulations having extended controlled release 104 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 106 1999
* 6,733,783 Controlled release hydrocodone formulations 84 2001
2004/0266,807 Controlled release hydrocodone formulations 20 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 48 1993
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 126 1993
5,502,058 Method for the treatment of pain 108 1994
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 116 1987
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 14 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 116 1993
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 129 1988
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 62 1996
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5,202,128 Sustained release pharmaceutical composition 142 1990
5,330,766 Sustained release pharmaceutical composition 107 1993
5,378,474 Sustained release pharmaceutical composition 109 1993
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 106 1983
 
Hoechst Aktiengesellschaft (1)
4,935,246 Process for the coating of granules 108 1988
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5,629,011 Composition for nasal administration 77 1994
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 154 1981
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 37 1989
5,133,974 Extended release pharmaceutical formulations 264 1990
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 36 1987
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 50 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 38 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 28 1991
 
DepoMed Systems, Inc. (1)
5,007,790 Sustained-release oral drug dosage form 156 1989
 
GLATT GMBH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 53 1991
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 60 1981
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 101 1984
5,178,868 Dosage form 59 1991
5,520,931 Controlled release morphine preparation 43 1995
 
Warner-Lambert Company (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 73 1983
4,600,645 Process for treating dosage forms 62 1985
5,068,110 Stabilization of enteric coated dosage form 60 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 76 1992
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 75 1988
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 249 1982
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 149 1986
4,970,075 Controlled release bases for pharmaceuticals 123 1989
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 28 1988
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 114 1986
 
ROHM GMBH (1)
4,520,172 Method for coating medicaments 46 1983
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 56 1991
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 46 1991
 
American Cyanamid Company (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 82 1992
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 110 1987
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 105 1989
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 66 1986
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 111 1990
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 53 1989
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
CIMA LABS INC. (2)
8,445,018 Abuse resistant drug formulation 8 2008
8,927,025 Alcohol-resistant metoprolol-containing extended-release oral dosage forms 0 2011
 
DEPOMED, INC. (4)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 2 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 2 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 3 2012
8,668,929 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
PURDUE PHARMA L.P. (6)
* 7,846,476 Once-a-day oxycodone formulations 14 2002
8,980,291 Controlled release hydrocodone formulations 0 2010
* 8,551,520 Controlled release hydrocodone 4 2012
8,975,271 Controlled release hydrocodone formulations 0 2013
8,975,273 Controlled release hydrocodone formulations 0 2014
8,951,555 Controlled release hydrocodone formulations 0 2014
 
MALLINCKRODT INC. (4)
8,597,681 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans 0 2011
8,858,963 Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia 0 2012
8,741,885 Gastric retentive extended release pharmaceutical compositions 0 2012
8,658,631 Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia 0 2012
 
EGALET LTD. (2)
8,877,241 Morphine controlled release system 0 2004
8,808,745 Morphine polymer release system 0 2013
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 7, 2016
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 7, 2020
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00